Author

H.-C. Lai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. S.-T. Wong· 1 shared B. Lian· 1 shared C. Yi· 1 shared C.-C. Chen· 1 shared C.-C. Hsu· 1 shared C.-T. Ho· 1 shared F. Meng· 1 shared H.-B. Zou· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. S.-T. Wong

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Bola-amphiphilic dendrimer empowers imatinib to target metastatic ovarian cancer stem cells via beta-catenin-HRP2 signaling axis

Z. Shi, M. Artemenko, M. Zhang, C. Yi, P. Chen, S. Lin, Z. Bian, B. Lian, F. Meng, J. Chen, T. Roussel, Y. Li, K. K. L. Chan, P. P. C. Ip, H.-C. Lai, , A. S.-T. Wong

This study develops a nanoformulation Bola/IM to target metastatic ovarian cancer stem cells via the beta-catenin-HRP2 signaling axis, showing improved efficacy and synergy with cisplatin.

bioRxiv · Jun 7, 2024 · PreprintCancer Biology

Dietary Exposure to Antibiotic Residues Facilitates Metabolic Disorder by Altering the Gut Microbiota and Bile Acid Composition

R.-A. Chen, W.-K. Wu, S. Panyod, P.-Y. Liu, H.-L. Chuang, Y.-H. Chen, Q. Lyu, H.-C. Hsu, T.-L. Lin, T.-C. D. Shen, Y.-T. Yang, H.-B. Zou, H.-S. Huang, Y.-E. Lin, C.-C. Chen, , L.-Y. Sheen

This study shows that low-dose antibiotic residue exposure in early life alters gut microbiota and bile acid composition, leading to long-term metabolic disorders in mice.

bioRxiv · Jul 6, 2021Microbiology